TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Polypeptide Laboratories Holding (PPL) AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,869,445
|
1,756,399
|
1,253,351 |
| Financial expenses |
189,377
|
127,086
|
41,217 |
| Earnings before taxes |
-357,885
|
-336,442
|
-200,295 |
| EBITDA |
-292,002
|
-578,497
|
-158,678 |
| Total assets |
5,029,280
|
4,442,600
|
2,832,010 |
| Current assets |
1,372,714
|
1,515,975
|
549,252 |
| Current liabilities |
2,155,514
|
1,326,402
|
803,989 |
| Equity capital |
335,881
|
419,736
|
518,080 |
| - share capital |
212
|
203
|
189 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
6.7%
|
9.4%
|
18.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-19.1%
|
-19.2%
|
-16.0% |
| Return on assets (ROA) |
-3.4%
|
-4.7%
|
-5.6% |
| Current ratio |
63.7%
|
114.3%
|
68.3% |
| Return on equity (ROE) |
-106.6%
|
-80.2%
|
-38.7% |
| Change turnover |
81,376
|
414,114
|
409,431 |
| Change turnover % |
5%
|
31%
|
49% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.